Biologics and Biosimilars: Drug Discovery and Clinical Applications - Image 1

£45.07

CRC Press Biologics and Biosimilars: Drug Discovery and Clinical Applications

Name: Biologics and Biosimilars: Drug Discovery and Clinical Applications
Brand: CRC Press
Price: 45.07 GBP
Availability: InStock

Medical Technology

This is the most expensive it has ever been. Walk away.

£45 today · previous high £45 · all-time low £41

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 434 days • 434 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 434 days • 5 price levels

Days at Price

Current Price

Price Analysis

Most common price: £42 (351 days, 80.9%)

Price range: £41 - £45

Price levels: 5 different prices over 434 days

Description

Biologics and Biosimilars: Drug Discovery and Clinical Applications is a systematic integration and evaluation of all aspects of biologics and biosimilars, encompassing research and development, clinical use, global regulation, and more. Biosimilars are biological therapeutic agents designed to imitate a reference biologic with high similarities in structure, efficacy, and safety, but also with potential clinical effective and cost-efficient options for the manufacturers, payers, clinicians, and patients. Most of the top-selling prescription drugs in the current market are biologics, which have revolutionized the treatment strategies and modalities for life-threatening and/or rare diseases. This book outlines the key processes and challenges in drug development, regulations, and clinical applications of biologics, biosimilars, and even interchangeable biosimilars. Global experts in the field discuss essential categories and prototype drugs of biologics and biosimilars in clinical practice such as allergenics, blood and blood components, cell treatment, gene therapy, recombinant therapeutic proteins or peptides, tissues, and vaccines. Additional features: Integrates the latest bench and bedside evidence of drug development and regulations of biologics and biosimilars Contains key study questions for each chapter to guide the readers, as well as drug charts for all therapeutic applications of biologics and biosimilars Presents detailed schematic illustrations to explain the drug development, clinical trials, regulations, and clinical applications of biologics and biosimilars This book is an invaluable tool for health care professional students, providers, and pharmaceutical and health care industries, as well as the public, providing readers with educational updates about the drug development and clinical affairs of biological medications and their similar drugs.

Key Features

New Store Stock

Product Specifications

Brand: CRC Press
Format: Paperback
ASIN: 1032262028
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Medical Technology
Domain: Amazon UK
Release Date: 26 August 2024
Listed Since: 22 June 2024

Barcode

No barcode data available

CRC Press Biologics and Biosimilars: Drug Discovery and Clinical Applications

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars Development Strategies: Fast to Market Approaches

Biosimilars and Interchangeable Biologics: Strategic Elements

Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Mastering Strategic Marketing For Specialty Pharmaceuticals: A Hands-on Guide

Case Studies in Modern Drug Discovery and Development

Biopharmaceuticals: Challenges and Opportunities

Drug-Drug Interactions for Therapeutic Biologics

Digital Therapeutics: Strategic, Scientific, Developmental, and Regulatory Aspects (Chapman & Hall/CRC Biostatistics Series)

Basic Principles of Drug Discovery and Development

Biosimilars and Interchangeable Biologics: Strategic Elements

Medical Writing in Drug Development: A Practical Guide for Pharmaceutical Research

The 2023-2028 Outlook for Bioengineered Monoclonal Antibodies Protein Drugs in Japan

Introduction to Biological and Small Molecule Drug Research and Development: Theory and Case Studies

Biosimilars: A New Generation of Biologics

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Biosimilars: A New Generation of Biologics

Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals

The Thriving Biopharma Business: How to Unlock Value and Drive Success in Biotech and Pharma

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals